[Intracranial hemorrhage following second thrombolytic treatment of myocardial reinfarction].
Intracranial hemorrhage was observed in a man, aged 66, after a second thrombolytic treatment due to myocardial reinfarction. The patient presented no potential risk factors which have often been associated to intracranial hemorrhage whereas no complications had occurred when thrombolytic therapy was given some months before because of the first infarction. This report emphasizes that a previous thrombolytic treatment with no secondary effects involves no lack of intracranial hemorrhage risk for a second thrombolysis. More research is needed in order to elucidate intracranial hemorrhage mechanisms associated to thrombolytic therapy.
Valentín Segura
V
V
Unidad Coronaria, Hospital Dr. Peset Aleixandre, Valencia.
Valls Grima
F
F
Broch Porcar
M J
MJ
Miralles Serrano
L
L
Olivares Toledo
D
D
Alvarez Cebrián
F
F
D000368:Aged; D001241:Aspirin / Q000009:adverse effects; D002543:Cerebral Hemorrhage / Q000139:chemically induced*; D005260:Female; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy; D012008:Recurrence; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects
D006493:Heparin; D010959:Tissue Plasminogen Activator; D001241:Aspirin
Hemorragia intracraneal tras un segundo tratamiento trombolítico por reinfarto de miocardio.